174 related articles for article (PubMed ID: 23110149)
1. Transcutaneous immunization system using a hydrotropic formulation induces a potent antigen-specific antibody response.
Takatani-Nakase T; Tokuyama E; Komai M; Takahashi K
PLoS One; 2012; 7(10):e47980. PubMed ID: 23110149
[TBL] [Abstract][Full Text] [Related]
2. Application of hydrotropy to transdermal formulations: hydrotropic solubilization of polyol fatty acid monoesters in water and enhancement effect on skin permeation of 5-FU.
Takahashi K; Komai M; Kinoshita N; Nakamura E; Hou XL; Takatani-Nakase T; Kawase M
J Pharm Pharmacol; 2011 Aug; 63(8):1008-14. PubMed ID: 21718283
[TBL] [Abstract][Full Text] [Related]
3. The haemopoietic growth factor, Flt3L, alters the immune response induced by transcutaneous immunization.
Baca-Estrada ME; Ewen C; Mahony D; Babiuk LA; Wilkie D; Foldvari M
Immunology; 2002 Sep; 107(1):69-76. PubMed ID: 12225364
[TBL] [Abstract][Full Text] [Related]
4. The mode of protein antigen administration determines preferential presentation of peptide-class II complexes by lymph node dendritic or B cells.
Guéry JC; Ria F; Galbiati F; Smiroldo S; Adorini L
Int Immunol; 1997 Jan; 9(1):9-15. PubMed ID: 9043943
[TBL] [Abstract][Full Text] [Related]
5. Transcutaneous immunization with a novel imiquimod nanoemulsion induces superior T cell responses and virus protection.
Lopez PA; Denny M; Hartmann AK; Alflen A; Probst HC; von Stebut E; Tenzer S; Schild H; Stassen M; Langguth P; Radsak MP
J Dermatol Sci; 2017 Sep; 87(3):252-259. PubMed ID: 28655469
[TBL] [Abstract][Full Text] [Related]
6. Transcutaneous immunization with phosphorylcholine induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
Nagano H; Kurono Y
Auris Nasus Larynx; 2015 Dec; 42(6):478-82. PubMed ID: 26092312
[TBL] [Abstract][Full Text] [Related]
7. Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant.
Naito S; Maeyama J; Mizukami T; Takahashi M; Hamaguchi I; Yamaguchi K
Vaccine; 2007 Dec; 25(52):8762-70. PubMed ID: 18023509
[TBL] [Abstract][Full Text] [Related]
8. Effects of IL-12 on immune responses induced by transcutaneous immunization with antigens formulated in a novel lipid-based biphasic delivery system.
Baca-Estrada ME; Foldvari M; Ewen C; Badea I; Babiuk LA
Vaccine; 2000 Mar; 18(17):1847-54. PubMed ID: 10699333
[TBL] [Abstract][Full Text] [Related]
9. Transcutaneous immunization in auricle skin induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
Nagano H; Jimura T; Nagano M; Makise T; Miyashita K; Kurono Y
Auris Nasus Larynx; 2017 Aug; 44(4):411-416. PubMed ID: 27637556
[TBL] [Abstract][Full Text] [Related]
10. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.
Mishra D; Mishra PK; Dubey V; Nahar M; Dabadghao S; Jain NK
Eur J Pharm Sci; 2008 Apr; 33(4-5):424-33. PubMed ID: 18359615
[TBL] [Abstract][Full Text] [Related]
11. Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays.
Guo L; Qiu Y; Chen J; Zhang S; Xu B; Gao Y
Biomed Microdevices; 2013 Dec; 15(6):1077-85. PubMed ID: 23893014
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells and IL-10 independently counterregulate cytotoxic T lymphocyte responses induced by transcutaneous immunization.
Stein P; Weber M; Prüfer S; Schmid B; Schmitt E; Probst HC; Waisman A; Langguth P; Schild H; Radsak MP
PLoS One; 2011; 6(11):e27911. PubMed ID: 22114725
[TBL] [Abstract][Full Text] [Related]
13. Intranasal antigen targeting to MHC class II molecules primes local IgA and serum IgG antibody responses in mice.
Snider DP; Underdown BJ; McDermott MR
Immunology; 1997 Mar; 90(3):323-9. PubMed ID: 9155636
[TBL] [Abstract][Full Text] [Related]
14. 9-Phenanthrol enhances the generation of an CD8
Hartmann AK; Aranda Lopez P; Zajac M; Freichel M; Schild H; Radsak MP; Stassen M
J Dermatol Sci; 2017 Sep; 87(3):260-267. PubMed ID: 28823644
[TBL] [Abstract][Full Text] [Related]
15. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro.
Zhong G; Reis e Sousa C; Germain RN
J Exp Med; 1997 Aug; 186(5):673-82. PubMed ID: 9271583
[TBL] [Abstract][Full Text] [Related]
16. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.
Matsuo K; Yokota Y; Zhai Y; Quan YS; Kamiyama F; Mukai Y; Okada N; Nakagawa S
J Control Release; 2012 Jul; 161(1):10-7. PubMed ID: 22306332
[TBL] [Abstract][Full Text] [Related]
17. Skin vaccination via fractional infrared laser ablation - Optimization of laser-parameters and adjuvantation.
Scheiblhofer S; Strobl A; Hoepflinger V; Thalhamer T; Steiner M; Thalhamer J; Weiss R
Vaccine; 2017 Mar; 35(14):1802-1809. PubMed ID: 28117172
[TBL] [Abstract][Full Text] [Related]
18. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants.
Glenn GM; Scharton-Kersten T; Vassell R; Matyas GR; Alving CR
Infect Immun; 1999 Mar; 67(3):1100-6. PubMed ID: 10024549
[TBL] [Abstract][Full Text] [Related]
19. Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.
Hessenberger M; Weiss R; Weinberger EE; Boehler C; Thalhamer J; Scheiblhofer S
Vaccine; 2013 Jul; 31(34):3427-34. PubMed ID: 23273971
[TBL] [Abstract][Full Text] [Related]
20. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.
Anjuère F; George-Chandy A; Audant F; Rousseau D; Holmgren J; Czerkinsky C
J Immunol; 2003 Feb; 170(3):1586-92. PubMed ID: 12538724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
